Verified Nov 2026
Other
·

Conshohocken, Pennsylvania
·
Since 2016
Madrigal Pharmaceuticals is a biopharmaceutical company headquartered in Conshohocken, Pennsylvania, founded in 2016, with 500–1,000 employees and estimated revenue of $500 million to $1 billion. The company develops small-molecule therapeutics for cardiovascular, metabolic, and liver diseases. Its lead product, Rezdiffra, is the first FDA-approved treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with moderate-to-severe liver fibrosis.
Madrigal Pharmaceuticals at a glance
Revenue
$500M-1B
Est. band
Employees
500-1,000
Founded
2016
Headquarters
Conshohocken, Pennsylvania
Industries
Automotive
Electric Vehicles
Medical
Overview
Madrigal Pharmaceuticals is a biopharmaceutical company headquartered in Conshohocken, Pennsylvania, founded in 2016, with 500–1,000 employees and estimated revenue of $500 million to $1 billion. The company develops small-molecule therapeutics for cardiovascular, metabolic, and liver diseases. Its lead product, Rezdiffra, is the first FDA-approved treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with moderate-to-severe liver fibrosis.
At a glance
Attribute | Detail |
|---|---|
Founded | 2016 |
Headquarters | Conshohocken, Pennsylvania |
Employees | 500-1,000 |
Revenue | $500M-1B (estimated) |
What Madrigal Pharmaceuticals makes
The company's capabilities include drug discovery, small-molecule therapeutic development, clinical trial execution, and regulatory pathway navigation for liver fibrosis and metabolic disease treatments.
Latest developments
2026-11-03 — Madrigal Pharmaceuticals Reports Third-Quarter 2026 Financial Results and Provides Corporate Updates | Madrigal Pharmaceuticals, Inc. (gcs-web.com)
2026-08-17 — Madrigal斥资10亿美元收购Arrowhead的siRNA MASH药物资产 - 创新药物 - 家医大健康 (familydoctor.cn)
2026-05-06 — Madrigal Pharmaceuticals Reports First-Quarter 2026 Financial Results and Provides Corporate Updates | Madrigal Pharmaceuticals, Inc. (madrigalpharma.com)
2026-02-11 — Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs | Madrigal Pharmaceuticals, Inc. (madrigalpharma.com)
2025-07-30 — Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited | Madrigal Pharmaceuticals, Inc. (madrigalpharma.com)
2025-07-30 — Madrigal signs potential $2 billion-plus deal with China's CSPC to develop liver drug (reuters.com)
Company details
Madrigal is a privately held biopharmaceutical firm with a team of approximately 528 employees focused on advancing metabolic health management and early diagnosis and treatment of liver diseases. Madrigal Pharmaceuticals was founded in 2016, has an estimated 500-1,000 employees, and is headquartered in Conshohocken, Pennsylvania.
Frequently asked questions
What does Madrigal Pharmaceuticals do?
Madrigal Pharmaceuticals is a biopharmaceutical company headquartered in Conshohocken, Pennsylvania, founded in 2016, with 500–1,000 employees and estimated revenue of $500 million to $1 billion. The company develops small-molecule therapeutics for cardiovascular, metabolic, and liver diseases. Its lead product, Rezdiffra, is the first FDA-approved treatment for Metabolic Dysfunction-Associated Steatohepatitis (MASH) with moderate-to-severe liver fibrosis.
Where is Madrigal Pharmaceuticals headquartered?
Madrigal Pharmaceuticals is headquartered in Conshohocken, Pennsylvania (200 Barr Harbor Drive, Conshohocken, Pennsylvania, 19428).
When was Madrigal Pharmaceuticals founded?
Madrigal Pharmaceuticals was founded in 2016.
How big is Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $500M-1B range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
